498 related articles for article (PubMed ID: 11145252)
21. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
[TBL] [Abstract][Full Text] [Related]
22. Superficial malignant peripheral nerve sheath tumor with overlying intradermal melanocytic nevus mimicking spindle cell melanoma.
Jackson CR; Minca EC; Kapil JP; Smith SC; Billings SD
J Cutan Pathol; 2016 Dec; 43(12):1220-1225. PubMed ID: 27687011
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic and biological implications of mel-CAM expression in mesenchymal neoplasms.
Shih IM; Wang TL; Westra WH
Clin Cancer Res; 1996 Mar; 2(3):569-75. PubMed ID: 9816205
[TBL] [Abstract][Full Text] [Related]
24. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms.
Campbell LK; Thomas JR; Lamps LW; Smoller BR; Folpe AL
Mod Pathol; 2003 Oct; 16(10):963-9. PubMed ID: 14559978
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma.
Choy B; Hyjek E; Montag AG; Pytel P; Haydon R; Luu HH; Zhen CJ; Long BC; Kadri S; Segal JP; Furtado LV; Cipriani NA
Histopathology; 2017 Apr; 70(5):734-745. PubMed ID: 27926791
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP
Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical characteristics of melanoma.
Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
[TBL] [Abstract][Full Text] [Related]
28. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
29. New phenotypical and ultrastructural findings in spindle cell (desmoplastic/neurotropic) melanoma.
Winnepenninckx V; De Vos R; Stas M; van den Oord JJ
Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):319-25. PubMed ID: 14663357
[TBL] [Abstract][Full Text] [Related]
30. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.
Sheffield MV; Yee H; Dorvault CC; Weilbaecher KN; Eltoum IA; Siegal GP; Fisher DE; Chhieng DC
Am J Clin Pathol; 2002 Dec; 118(6):930-6. PubMed ID: 12472287
[TBL] [Abstract][Full Text] [Related]
31. MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma.
Ferenczi K; Lastra RR; Farkas T; Elenitsas R; Xu X; Roberts S; Brooks JS; Zhang PJ
Int J Surg Pathol; 2012 Feb; 20(1):29-36. PubMed ID: 21903680
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?
Gaspard M; Lamant L; Tournier E; Valentin T; Rochaix P; Terrier P; Ranchere-Vince D; Coindre JM; Filleron T; Le Guellec S
Histopathology; 2018 Dec; 73(6):969-982. PubMed ID: 30137667
[TBL] [Abstract][Full Text] [Related]
33. Expression of claudin-1 in canine peripheral nerve sheath tumours and perivascular wall tumours. Immunohistochemical study.
Jakab C; Gálfi P; Jerzsele Á; Szabó Z; Németh T; Sterczer Á; Rusvai M; Ózsvári L
Histol Histopathol; 2012 Jul; 27(7):905-17. PubMed ID: 22648546
[TBL] [Abstract][Full Text] [Related]
34. Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma.
Cruz J; Reis-Filho JS; Lopes JM
J Clin Pathol; 2004 Feb; 57(2):218-20. PubMed ID: 14747458
[TBL] [Abstract][Full Text] [Related]
35. Sox10: a pan-schwannian and melanocytic marker.
Nonaka D; Chiriboga L; Rubin BP
Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
[TBL] [Abstract][Full Text] [Related]
36. Desmoplastic melanoma may mimic a cutaneous peripheral nerve sheath tumor: Report of 3 challenging cases.
Machado I; Llombart B; Cruz J; Traves V; Requena C; Nagore E; Parafioriti A; Monteagudo C; Llombart-Bosch A
J Cutan Pathol; 2017 Jul; 44(7):632-638. PubMed ID: 28403573
[TBL] [Abstract][Full Text] [Related]
37. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
[TBL] [Abstract][Full Text] [Related]
38. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
[TBL] [Abstract][Full Text] [Related]
39. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
40. PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis.
Hrycaj SM; Szczepanski JM; Zhao L; Siddiqui J; Thomas DG; Lucas DR; Patel RM; Harms PW; Bresler SC; Chan MP
Histopathology; 2022 Dec; 81(6):818-825. PubMed ID: 36102613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
